Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis

Perakakis, Nikolaos; Bornstein, Stefan R.; Birkenfeld, Andreas L.; Linkermann, Andreas; Demir, Muenevver; Anker, Stefan D.; Filippatos, Gerasimos; Pitt, Bertram; Rossing, Peter; Ruilope, Luis M.; Kolkhof, Peter; Lawatscheck, Robert; Scott, Charlie; Bakris, George L.

Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis

Autor(en):

Perakakis, Nikolaos; Bornstein, Stefan R.; Birkenfeld, Andreas L.; Linkermann, Andreas; Demir, Muenevver; Anker, Stefan D.; Filippatos, Gerasimos; Pitt, Bertram; Rossing, Peter; Ruilope, Luis M.; Kolkhof, Peter; Lawatscheck, Robert; Scott, Charlie; Bakris, George L.

Tübinger Autor(en):

Birkenfeld, Andreas L.

Erschienen in:

Diabetes Obesity & Metabolism (2024), Bd. 26, H. 1, S. 191-200

Verlagsangabe:

Hoboken : Wiley

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1111/dom.15305

ISSN:

1462-8902